Interpretation of low reactivity in the Abbott Architect rHTLV I/II assay

ConclusionsSamples with an S/CO ratio of <4·0 on the Abbott Architect rHTLV I/II platform represent a low risk of HTLV infection in the UK, and organs from such donors might reasonably be considered for transplantation, within the context of appropriate risk–benefit assessment.

Source: Transfusion Medicine - September 1, 2017 Category: Hematology Authors: J. H. C. Tosswill, G. P. Taylor Tags: SHORT COMMUNICATION Source Type: research